FDA approves Jalyn, a fixed-dose combination of dutasteride and tamsulosin, for symptomatic BPH in men with an enlarged prostate
Links shared publicly online about this topic.
- 1,087total visits
FDA approves Jalyn, a fixed-dose combination of dutasteride and tamsulosin, for symptomatic BPH in men with an enlarged prostate
View full resource at drugs.com
Tags: Prostate, Benign Prostatic Hypertrophy Medication, Men's Health, FDA, Flomax, Harnal, Avodart
Most Recently Shared on June 17, 2010 at 11:05 pm By:
FDA approves Jalyn for symptomatic BPH in men with an enlarged prostate - http://bit.ly/cbAgdy
Jalyn approved for benign prostatic hyperplasia (BPH) - MPR
empr.com — “The FDA has approved GlaxoSmithKline's Jalyn, a fixed dose combination of dutasteride and tamsulosin, for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.” View full resource at empr.com
Most Recently Shared on June 16, 2010 at 4:50 pm By:
MPR News: Jalyn approved for benign prostatic hyperplasia (BPH): The FDA has approved GlaxoSmithKline's Jalyn, a f... http://bit.ly/9TE4CU
Jalyn approved for benign prostatic hyperplasia (BPH) - ONA
oncologynurseadvisor.com — “The FDA has approved GlaxoSmithKline--™s Jalyn, a fixed dose combination of dutasteride and tamsulosin, for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 16, 2010 at 3:56 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Jalyn approved for benign prostatic hyperplasia (BPH) http://goo.gl/fb/46Mff
Advertisement
